SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 8-K
Document Type: EX-1.1
Date Filed: 2025-08-27
Accession Number: 0001213900-25-081175
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025081175/ea025480001ex1-1_synergy.htm

Chunk 26 of 27
Word Count: 686
Character Count: 4163

Document Content:

a transfer of shares of Common Stock, the Representative will notify the Company of the impending release or waiver, and (ii) the Company will agree in the Underwriting Agreement to announce the impending release or waiver by press release through a major news service at least two business days before the effective date of the release or waiver. Any release or waiver granted by the Representative hereunder to any such officer or director shall only be effective two business days after the publication date of such press release. The provisions of this paragraph will not apply if (a) the release or waiver is effected solely to permit a transfer not for consideration and (b) the transferee has agreed in writing to be bound by the same terms described in this letter to the extent and for the duration that such terms remain in effect at the time of the transfer.

In the event that, during
the Lock-Up Period, the Representative releases or waives any prohibition set forth in this Lock-Up Agreement (or in any similar lock-up
agreement) on the transfer of Common Stock or other Company securities held by any securityholder of the Company owning, directly or indirectly,
more than 1% of the shares of Common Stock issued and outstanding immediately prior to the Offering, an amount of Common Stock and other
Company securities subject to this agreement representing the same percentage of the total number of outstanding Common Stock and other
Company securities subject to this agreement and held by the undersigned as the percentage of the total number of outstanding Common Stock
and other Company securities held by such other person or entity that are the subject of such release or waiver shall be immediately and
fully released on the same terms from the applicable prohibitions set forth herein. The Representative shall promptly notify the Company
and the undersigned of any such release.

The undersigned understands
that, if the Underwriting Agreement does not become effective, if the Underwriting Agreement (other than the provisions thereof which
survive termination) shall terminate or be terminated prior to payment for and delivery of the securities to be sold thereunder, or if
the Registration Statement filed with the SEC in connection with the Offering is withdrawn, the undersigned shall be released from all
obligations under this Lock-Up Agreement.

This Lock-Up Agreement shall
be governed by and construed in accordance with the law of the State of New York. The undersigned irrevocably (i) submits to the jurisdiction
of the Supreme Court of the State of New York, and the United States District Court for the Southern District of New York, in each case
sitting in the City and County of New York, for the purpose of any suit, action, or other proceeding arising out of this Lock-Up Agreement
(each a “Proceeding”), (ii) agrees that all claims in respect of any Proceeding may be heard and determined in any such court,
(iii) waives, to the fullest extent permitted by law, any immunity from jurisdiction of any such court or from any legal process therein,
(iv) agrees not to commence any Proceeding other than in such courts, and (v) waives, to the fullest extent permitted by law, any claim
that such Proceeding is brought in an inconvenient forum.

Very truly yours,

Name:

EXHIBIT C

Form of Press Release

Synergy CHC Corp.

[Date]

Synergy CHC Corp., a Nevada corporation (the “Company”)
announced today that Bancroft Capital, LLC the [Representative] in the Company’s recent public sale of shares of common stock are
[waiving][releasing] a lock-up restriction with respect to shares of the Company’s common stock held by [certain officers or directors]
[an officer or director] of the Company. The [waiver][release] will take effect on , 20 , and the shares may be sold on or after such
date.

This press release is not an offer for sale
of the securities in the United States or in any other jurisdiction where such offer is prohibited, and such securities may not be offered
or sold in the United States absent registration or an exemption from registration under the United States Securities Act of 1933, as
amended.